市場調查報告書
商品編碼
1028667

全球過敏和免疫市場(按治療類型、過敏類型、分銷渠道、地區(北美、歐洲、亞太地區、拉丁美洲、中東/非洲)):趨勢分析,按公司劃分的市場份額,未來預測(2017-2027)

Global Allergy and Immunology Market, By Treatment Type By Allergy Type, By Distribution Channel,By Region (North America, Europe, Asia-Pacific, Latin America, Middle-East & Africa Trend Analysis, Competitive Market Share & Forecast, 2017-2027

出版日期: | 出版商: Blueweave Consulting & Research Private Limited | 英文 197 Pages | 商品交期: 請詢問到貨日

價格
  • 全貌
  • 簡介
  • 目錄
簡介

2020年全球過敏和免疫市場規模達到21億美元。它將繼續以 11.2% 的複合年增長率增長,預計到 2027 年底將達到約 45 億美元。市場上的主要驅動因素是各種過敏症(食物過敏、花粉症、寵物過敏)的患病率增加和研究活動的激活。自身免疫性疾病的流行也有助於促進全球市場的發展。

按地區劃分,歐洲國家的份額最大,其次是北美。預計北美國家未來也將顯示出最高的複合年增長率。

本報告分析全球過敏/免疫市場,分析市場基本結構、推動/抑制因素、市場整體、治療類型、過敏類型、分銷渠道、展望各地區的趨勢 我們正在調查市場策略的趨勢和案例,主要公司的簡介等。

目錄

第 1 章分析框架

第 2 章調查方法

第 3 章執行摘要

第 4 章行業考慮與增長戰略

  • 價值鏈分析
  • DROC 分析
    • 市場促進因素
      • 發達國家食物過敏的流行率增加
      • 擴大過敏/免疫相關的研發 (R & D) 活動
    • 市場抑制因素
      • 缺乏過敏和免疫意識
    • 市場挑戰
      • 過敏治療費用高
    • 市場機會
      • 自身免疫性疾病的患病率增加
      • 提供多種過敏治療
  • 近期趨勢
  • 波特五力分析

第 5 章全球過敏和免疫市場:概述

  • 市場規模及其預測(金額基準,2017-2027)
  • 市場規模及其預測:按細分市場
    • 按治療類型
      • 皮下免疫療法 (SCIT)
      • 舌下免疫療法 (SLIT)
    • 按過敏類型
      • 過敏性鼻炎
      • 過敏性哮喘
      • 其他過敏
    • 按分銷渠道
      • 醫院藥房
      • 零售藥店
      • 網上藥店
    • 按地區
      • 北美
      • 歐洲
      • 亞太地區
      • 拉丁美洲
      • 中東/非洲

第 6 章北美過敏和免疫市場:概述

  • 市場規模及其預測
    • 以金額為基礎(單位:10億美元,2020-2027)
  • 市場份額及其預測
    • 按治療類型
    • 按過敏類型
    • 按分銷渠道
    • 按國家/地區
      • 美國
      • 加拿大

第 7 章歐洲過敏和免疫市場:概述

  • 市場規模及其預測
  • 市場份額及其預測
    • 按國家/地區
      • 德國
      • 英國
      • 俄羅斯
      • 法國
      • 意大利
      • 西班牙
      • 其他歐洲國家

第 8 章亞太地區過敏和免疫市場:概述

  • 市場規模及其預測
  • 市場份額及其預測
    • 按國家/地區
      • 中國
      • 印度
      • 日本
      • 韓國
      • 其他亞太國家

第 9 章拉丁美洲過敏和免疫市場:概述

  • 市場規模及其預測
  • 市場份額及其預測
    • 按國家/地區
      • 墨西哥
      • 巴西
      • 其他拉美國家市場

第 10 章中東/非洲過敏/免疫市場:概述

  • 市場規模及其預測
  • 市場份額及其預測
    • 按國家/地區
      • 沙特阿拉伯
      • 阿拉伯聯合酋長國
      • 南非
      • 其他中東和非洲國家的市場

第 11 章競爭形勢

  • 主要公司及其產品列表
  • 市場份額分析(2020 年)
  • 公司間對比分析:按參數

第 12 章 COVID-19 對全球過敏和免疫市場的影響

第 13 章公司概況(公司概況、財務矩陣、關鍵產品環境、公司高管、主要競爭對手、聯繫信息、SWOT 分析、公司戰略展望)

  • ALK-Abello A/S
  • Teva Pharmaceutical Industries
  • AbbVie Inc.
  • Stallergenes Greer PLC
  • Allergy Therapeutics
  • Sanofi SA
  • Anacor Pharmaceuticals Inc.
  • Novartis International AG
  • AstraZeneca
  • Merck KGaA
  • F. Hoffmann-La Roche Ltd
  • Leti Pharma
  • Galderma SA
  • Johnson & Johnson
  • GlaxoSmithKline PLC
  • Circassia
  • DESENTUM OY
  • HAL Allergy B.V.
  • Mylan N.V.
  • Other Prominent Players

第 14 章戰略建議

目錄
Product Code: BWC2173

Global Allergy and Immunology Market Booming: Growing at a CAGR of 11.2% in the Forecast Period

The global allergy and immunology market is gaining traction due to a number of factors including a growing number of allergies, including food allergies, pollen allergies, and pet allergies. Moreover, research and development activities for investigating the causes and treatments of allergies is also favoring the market growth...

A recent study conducted by the strategic consulting and market research firm BlueWeave Consulting revealed that the global allergy and immunology market was worth USD 2.1 billion in 2020. The market is estimated to grow at a CAGR of 11.2%, earning revenue of around USD 4.5 billion by the end of 2027. The global allergy and immunology market is growing at a rapid rate due to the increasing prevalence of allergies, such as food allergies, pollen allergies, pet allergies, etc., as well as growing research activities. The healthcare system is burdened with complex allergy problems, which drives R&D for the development of new medicines. However, the lack of awareness regarding allergy and immunology may act as a barrier to market growth.

Increasing Prevalence of Autoimmune Diseases is Boosting the Global Allergy & Immunology Market

It has been estimated that around 4% of the world's population is affected by autoimmune diseases, among which type 1 diabetes, multiple sclerosis, lupus, etc., are very common. Scientists claim that with the growing prevalence of autoimmune diseases, the market for allergy and immunology will flourish in the near future. Additionally, with the increasing awareness regarding these conditions in developed and developing countries alike, along with increasing research efforts towards these health conditions, the global allergy & immunology market is projected to grow.

Availability of Wide Range of Allergy Treatment Drugs Is Driving the Growth of The Global Allergy & Immunology Market

The availability of a broad spectrum of allergy drugs is also influencing the growth of the global allergy & immunology market.The availability of various drugs such as monoclonal antibodies, fusion proteins, immunosuppressants, polyclonal antibodies, and others in pharmacies and online stores is influencing market growth significantly. Among these drugs, the demand for monoclonal antibodies is very prominent in the allergy & immunology market because of their high efficiency in the treatment of autoimmune diseases and other rare conditions.

Global Allergy & Immunology Market - By Distribution Channel

Based on distribution channels, the global allergy & immunology market is segmented into hospital pharmacy, retail pharmacy, and online pharmacy. Among these, the hospital pharmacy segment accounts for the largest market share because of the increasing patient pool approaching hospitals for the treatment of different types of allergies. Moreover, many allergy drugs and shots are available in hospital pharmacies upon prescription. However, online pharmacies are gaining traction, especially since the COVID-19 outbreak, as people nowadays prefer buying medications online rather than stepping outside of the home in order to adhere to social distancing. Pharmaceutical businesses make a variety of drugs available through online stores and websites, which can even be subscribed to.

Global Allergy & Immunology Market - Regional Insights

Geographically, the global allergy & immunology market is segmented into North America, Europe, Asia-Pacific, Latin America, Middle-East & Africa. Among these regions, Europe accounts for the largest share in the market, followed by North America. The presence of a strong healthcare system and potentially high awareness regarding the presence of allergic treatments and immunology is propelling the growth of the allergy & immunology market in the European market. North America also covers a substantial market share and is expected to witness the highest CAGR because of the growing prevalence of food allergies and increasing research activities in immunology.

Impact of COVID-19 on Global Allergy & Immunology Market

One of the few markets that have been able to withstand the COVID-19 pandemic is the global allergy and immunology market. While the prevalence of allergic disorders increased during the quarantine period, the need for allergies treatment and drugs remained stable and even experienced a significant surge. Furthermore, pharmaceutical companies made their products and treatments available online and streamlined their distribution channels, making it easier for them to meet demand.

Competitive Landscape

The leading market players in the global allergy & immunology market are ALK-Abello A/S, Teva Pharmaceutical Industries, AbbVie Inc., Stallergenes Greer PLC, Allergy Therapeutics, Sanofi SA, Anacor Pharmaceuticals Inc., Novartis International AG, AstraZeneca, Merck KGaA, F. Hoffmann-La Roche Ltd, Leti Pharma, Galderma SA, Johnson & Johnson, GlaxoSmithKline PLC, Circassia, DESENTUM OY, HAL Allergy B.V., Mylan N.V., and other prominent players.

The global allergy & immunology market is highly consolidated with the presence of several global as well as regional industry players. Research and development activities are heavily intensive in this market. The market players consistently focus on launching a variety of products that target relief for various types of allergies.Furthermore, the adoption of competitive strategies like partnerships, mergers, collaborations, mergers & acquisitionsis also very prominent in this market.

Don't miss the business opportunity of the global allergy & immunology market. Consult our analysts to gain crucial insights and facilitate your business growth.

The in-depth analysis of the report provides information about growth potential, upcoming trends, and statistics of the global allergy & immunology market. It also highlights the factors driving forecasts of total market size. The report promises to provide recent technology trends of the global allergy & immunology market and industry insights to help decision-makers make sound strategic decisions. Furthermore, the report also analyses the growth drivers, challenges, and competitive dynamics of the market.

About Us

BlueWeave Consulting provides comprehensive Market Intelligence (MI) Solutions to businesses regarding various products and services online and offline. We offer all-inclusive market research reports by analyzing both qualitative and quantitative data to boost up the performance of your business solutions. BWC has built its reputation from the scratch by delivering quality inputs and nourishing long-lasting relationships with its clients. We are one of the promising digital MI solutions companies providing agile assistance to make your business endeavors successful.

Table of Contents

1. Research Framework

  • 1.1. Research Objective
  • 1.2. Product Overview
  • 1.3. Key Market Segments

2. Research Methodology

  • 2.1. Qualitative Research
  • 2.2. Methodology
  • 2.3. Regional Split of Primary & Secondary Research
  • 2.4. Secondary Research
  • 2.5. Primary Research
    • 2.5.1. Breakdown of Primary Research Respondents, By Region
    • 2.5.2. Breakdown of Primary Research Respondents, By Industry Participants
  • 2.6. Market Size Estimation
  • 2.7. Assumptions for the Study
  • 2.8. Market Breakdown & Data Triangulation

3. Executive Summary

4. Industry Insight and Growth Strategy

  • 4.1. Value Chain Analysis
  • 4.2. DROC Analysis
    • 4.2.1. Market Drivers
      • 4.2.1.1. Increasing Prevalence of Food Allergies In Developed Countries
      • 4.2.1.2. Expanding Research and Development Activities Regarding Allergy and Immunology
    • 4.2.2. Market Restraints
      • 4.2.2.1. Lack of Awareness Towards Allergy and Immunotherapy
    • 4.2.3. Market Challenges
      • 4.2.3.1. High Cost of Allergy Treatment
    • 4.2.4. Market Opportunity
      • 4.2.4.1. Increasing Prevalence of Autoimmune diseases
      • 4.2.4.2. Availability of Wide Range of Allergy Treatment Drugs
  • 4.3. Recent Developments
  • 4.4. Porter's Five Forces Analysis
    • 4.4.1. Bargaining Power of Buyers
    • 4.4.2. Bargaining Power of Suppliers
    • 4.4.3. Intensity of Rivalry
    • 4.4.4. Threat of New Entrants
    • 4.4.5. Threat of Substitutes

5. Global Allergy & Immunology Market Overview

  • 5.1. Market Size & Forecast by Value, 2017-2027
  • 5.2. Market Size and Forecast, By Segment
    • 5.2.1. By Treatment Type
      • 5.2.1.1. Subcutaneous Immunotherapy (SCIT)
      • 5.2.1.2. Sublingual Immunotherapy (SLIT)
      • 5.2.1.2.1. Tablets
      • 5.2.1.2.2. Drops
    • 5.2.2. By Allergy Type
      • 5.2.2.1. Allergic Rhinitis
      • 5.2.2.2. Allergic Asthma
      • 5.2.2.3. Other Allergies
    • 5.2.3. By Distribution Channel
      • 5.2.3.1. Hospital Pharmacy
      • 5.2.3.2. Retail Pharmacy
      • 5.2.3.3. Online Pharmacy
    • 5.2.4. By Region
      • 5.2.4.1. North America
      • 5.2.4.2. Europe
      • 5.2.4.3. The Asia-Pacific
      • 5.2.4.4. Latin America
      • 5.2.4.5. The Middle East &Africa

6. North America Allergy & Immunology Market Overview

  • 6.1. Market Size and Forecast
    • 6.1.1. By Value (USDBillion), 2020-2027
  • 6.2. Market Share and Forecast
    • 6.2.1. By Treatment Type
    • 6.2.2. By Allergy Type
    • 6.2.3. By Distribution Channel
    • 6.2.4. By Country
      • 6.2.4.1. U.S.
      • 6.2.4.2. Canada

7. Europe Allergy & Immunology Market Overview

  • 7.1. Market Size and Forecast
    • 7.1.1. By Value (USDBillion), 2020-2027
  • 7.2. Market Share and Forecast
    • 7.2.1. By Treatment Type
    • 7.2.2. By Allergy Type
    • 7.2.3. By Distribution Channel
    • 7.2.4. By Country
      • 7.2.4.1. Germany
      • 7.2.4.2. U.K.
      • 7.2.4.3. Russia
      • 7.2.4.4. France
      • 7.2.4.5. Italy
      • 7.2.4.6. Spain
      • 7.2.4.7. Rest of Europe

8. APAC Allergy & Immunology Market Overview

  • 8.1. Market Size and Forecast
    • 8.1.1. By Value (USDBillion), 2020-2027
  • 8.2. Market Share and Forecast
    • 8.2.1. By Treatment Type
    • 8.2.2. By Allergy Type
    • 8.2.3. By Distribution Channel
    • 8.2.4. By Country
      • 8.2.4.1. China
      • 8.2.4.2. India
      • 8.2.4.3. Japan
      • 8.2.4.4. South Korea
      • 8.2.4.5. Rest of APAC

9. LATAM Allergy & Immunology Market Overview

  • 9.1. Market Size and Forecast
    • 9.1.1. By Value (USDBillion), 2020-2027
  • 9.2. Market Share and Forecast
    • 9.2.1. By Treatment Type
    • 9.2.2. By Allergy Type
    • 9.2.3. By Distribution Channel
    • 9.2.4. By Country
      • 9.2.4.1. Mexico
      • 9.2.4.2. Brazil
      • 9.2.4.3. Rest of LATAM

10. MEA Allergy & Immunology Market Overview

  • 10.1. Market Size and Forecast
    • 10.1.1. By Value (USDBillion), 2020-2027
  • 10.2. Market Share and Forecast
  • 10.3. By Treatment Type
  • 10.4. By Allergy Type
  • 10.5. By Distribution Channel
  • 10.6. By Country
    • 10.6.1. Saudi Arabia
    • 10.6.2. UAE
    • 10.6.3. South Africa
    • 10.6.4. Rest of MEA

11. Competitive Landscape

  • 11.1. List of Key Players and Their Offerings
  • 11.2. Market Share Analysis (2020)
  • 11.3. Competitive Benchmarking By Operating Parameters

12. Impact of COVID-19 on Global Allergy & Immunology Market

13. Company Profiles (Company Overview, Financial Matrix, Key Product landscape, Key Personnel, Key Competitors, Contact Address, and Strategic Outlook) *

  • 13.1. ALK-Abello A/S
  • 13.2. Teva Pharmaceutical Industries
  • 13.3. AbbVie Inc.
  • 13.4. Stallergenes Greer PLC
  • 13.5. Allergy Therapeutics
  • 13.6. Sanofi SA
  • 13.7. Anacor Pharmaceuticals Inc.
  • 13.8. Novartis International AG
  • 13.9. AstraZeneca
  • 13.10. Merck KGaA
  • 13.11. F. Hoffmann-La Roche Ltd
  • 13.12. Leti Pharma
  • 13.13. Galderma SA
  • 13.14. Johnson & Johnson
  • 13.15. GlaxoSmithKline PLC
  • 13.16. Circassia
  • 13.17. DESENTUM OY
  • 13.18. HAL Allergy B.V.
  • 13.19. Mylan N.V.
  • 13.20. Other Prominent Players

14. Key Strategic Recommendations

List of Figures

  • Figure 1: Global Allergy & Immunology Segmentation
  • Figure 2: Global Allergy & Immunology Market Value Chain Analysis,
  • Figure 3: Company Market Share Analysis, 2020
  • Figure 4: Global Allergy & Immunology Market Size, By Value (USD Billion), 2020-2027
  • Figure 5: Global Allergy & Immunology Market Share (%), By Treatment Type, By Value, 2020-2027
  • Figure 6: Global Allergy & Immunology Market Share (%), By Allergy Type, By Value, 2020-2027
  • Figure 7: Global Allergy & Immunology Market Share (%), By Distribution Channel, By Value, 2020-2027
  • Figure 8: Global Allergy &Immunology Market Share (%), By Region, By Value, 2020-2027
  • Figure 9: North America Allergy & Immunology Market Size, By Value (USD Billion), 2020-2027
  • Figure 10: North America Allergy & Immunology Market Share (%), By Treatment Type, By Value, 2020-2027
  • Figure 11: North America Allergy & Immunology Market Share (%), By Allergy Type, By Value, 2020-2027
  • Figure 12: North America Allergy & Immunology Market Share (%), By Distribution Channel, By Value, 2020-2027
  • Figure 13: North America Allergy & Immunology Market Share (%), By Country, By Value, 2020-2027
  • Figure 14: Europe Allergy & Immunology Market Size, By Value (USD Billion), 2020-2027
  • Figure 15: Europe Allergy & Immunology Market Share (%), By Treatment Type, By Value, 2020-2027
  • Figure 16: Europe Allergy & Immunology Market Share (%), By Allergy Type, By Value, 2020-2027
  • Figure 17: Europe Allergy & Immunology Market Share (%), By Distribution Channel, By Value, 2020-2027
  • Figure 18: Europe Allergy & Immunology Market Share (%), By Country, By Value, 2020-2027
  • Figure 19: the Asia-Pacific Allergy & Immunology Market Size, By Value (USD Billion), 2020-2027
  • Figure 20: the Asia-Pacific Allergy & Immunology Market Share (%), By Treatment Type, By Value, 2020-2027
  • Figure 21: the Asia-Pacific Allergy & Immunology Market Share (%), By Allergy Type, By Value, 2020-2027
  • Figure 22: the Asia-Pacific Allergy & Immunology Market Share (%), By Distribution Channel, By Value, 2020-2027
  • Figure 23: the Asia-Pacific Allergy & Immunology Market Share (%), By Country, By Value, 2020-2027
  • Figure 24: Latin America Allergy & Immunology Market Size, By Value (USD Billion), 2020-2027
  • Figure 25: Latin America Allergy & Immunology Market Share (%), By Treatment Type, By Value, 2020-2027
  • Figure 26: Latin America Allergy & Immunology Market Share (%), By Allergy Type, By Value, 2020-2027
  • Figure 27: Latin America Allergy & Immunology Market Share (%), By Distribution Channel, By Value, 2020-2027
  • Figure 28: Latin America Allergy & Immunology Market Share (%), By Country, By Value, 2020-2027
  • Figure 29: Middle East & Africa Allergy & Immunology Market Size, By Value (USD Billion), 2020-2027
  • Figure 30: Middle East & Africa Allergy & Immunology Market Share (%), By Treatment Type, By Value, 2020-2027
  • Figure 31: Middle East & Africa Allergy & Immunology Market Share (%), By Allergy Type, By Value, 2020-2027
  • Figure 32: Middle East & Africa Allergy & Immunology Market Share (%), By Distribution Channel, By Value, 2020-2027

Figure33: Middle East & Africa Allergy & Immunology Market Share (%), By Region, By Value, 2020-2027

List of Tables

  • Table 1: Global Allergy & Immunology Market Size, By Treatment Type, By Value, 2020-2027
  • Table 2: Global Allergy & Immunology Market Size, By Allergy Type, By Value(USD Billion), 2020-2027
  • Table 3: Global Allergy & Immunology Market Size, By Distribution Channel, By Value(USD Billion), 2020-2027
  • Table 4: Global Allergy & Immunology Market Size, By Region, By Value(USD Billion), 2020-2027
  • Table 5: North America Allergy & Immunology Market Size, By Treatment Type, By Value (USD Billion), 2020-2027
  • Table 6: North America Allergy & Immunology Market Size, By Allergy Type, By Value (USD Billion), 2020-2027
  • Table 7: North America Allergy & Immunology Market Size, By Distribution Channel, By Value (USD Billion), 2020-2027
  • Table 8: North America Allergy & Immunology Market Size, By Country, By Value (USD Billion), 2020-2027
  • Table 9: Europe Allergy & Immunology Market Size, By Treatment Type, By Value (USD Billion), 2020-2027
  • Table 10: Europe Allergy & Immunology Market Size, By Allergy Type, By Value (USD Billion), 2020-2027
  • Table 11: Europe Allergy & Immunology Market Size, By Distribution Channel, By Value (USD Billion), 2020-2027
  • Table 12: Europe Allergy & Immunology Market Size, By Country, By Value (USD Billion), 2020-2027
  • Table 13: the Asia-Pacific Allergy & Immunology Market Size, By Treatment Type, By Value (USD Billion), 2020-2027
  • Table 14: the Asia-Pacific Allergy & Immunology Market Size, By Allergy Type, By Value (USD Billion), 2020-2027
  • Table 15: the Asia-Pacific Allergy & Immunology Market Size, By Distribution Channel, By Value (USD Billion), 2020-2027
  • Table 16: the Asia-Pacific Allergy & Immunology Market Size, By Country, By Value (USD Billion), 2020-2027
  • Table 17: Latin America Allergy & Immunology Market Size, By Treatment Type, By Value (USD Billion), 2020-2027
  • Table 18: Latin America Allergy & Immunology Market Size, By Allergy Type, By Value (USD Billion), 2020-2027
  • Table 19: Latin America Allergy & Immunology Market Size, By Distribution Channel, By Value (USD Billion), 2020-2027
  • Table 20: Latin America Allergy & Immunology Market Size, By Country, By Value (USD Billion), 2020-2027
  • Table 21: The Middle-East & Africa Allergy & Immunology Market Size, By Treatment Type, By Value (USD Billion), 2020-2027
  • Table 22: The Middle-East & Africa Allergy & Immunology Market Size, By Allergy Type, By Value (USD Billion), 2020-2027
  • Table 23: The Middle-East & Africa Allergy & Immunology Market Size, By Distribution Channel, By Value (USD Billion), 2020-2027
  • Table 24: The Middle-East & Africa Allergy & Immunology Market Size, By Country, By Value (USD Billion), 2020-2027
  • Table 25: ALK-Abello A/S Financial Analysis
  • Table 26: ALK-Abello A/S Business Overview
  • Table 27: Teva Pharmaceutical Industries Financial Analysis
  • Table 28: Teva Pharmaceutical IndustriesBusiness Overview
  • Table 29: AbbVie Inc. Corporation Financial Analysis
  • Table 30: AbbVie Inc. Corporation Business Overview
  • Table 31: Stallergenes Greer PLCFinancial Analysis
  • Table 32: Stallergenes Greer PLC Business Overview
  • Table 33: Allergy Therapeutics Financial Analysis
  • Table 34: Allergy Therapeutics Business Overview
  • Table 35: Sanofi SA Financial Analysis
  • Table 36: Sanofi SA Business Overview
  • Table 37: Anacor Pharmaceuticals Inc. Financial Analysis
  • Table 38: Anacor Pharmaceuticals Inc. Business Overview
  • Table 39: Novartis International AG Financial Analysis
  • Table 40:Novartis International AG Business Overview
  • Table 41: AstraZeneca Financial Analysis
  • Table 42: AstraZeneca Business Overview
  • Table 43: Merck KGaAFinancial Analysis
  • Table 44: Merck KGaA Business Overview
  • Table 45: F. Hoffmann-La Roche LtdFinancial Analysis
  • Table 46: F. Hoffmann-La Roche Ltd Financial Analysis
  • Table 47: Leti PharmaFinancial Analysis
  • Table 48: Leti Pharma Financial Analysis
  • Table 49: Galderma SA Financial Analysis
  • Table 50: Galderma SA Financial Analysis
  • Table 51: Johnson & JohnsonFinancial Analysis
  • Table 52: Johnson & Johnson Financial Analysis
  • Table 53: GlaxoSmithKline PLCFinancial Analysis
  • Table 54: GlaxoSmithKline PLC Financial Analysis
  • Table 55: CircassiaFinancial Analysis
  • Table 56: Circassia Financial Analysis
  • Table 57: DESENTUM OYFinancial Analysis
  • Table 58: DESENTUM OY Financial Analysis
  • Table 59: HAL Allergy B.V.Financial Analysis
  • Table 60: HAL Allergy B.V. Financial Analysis
  • Table 61: Mylan N.V.Financial Analysis
  • Table 62: Mylan N.V. Financial Analysis